T1	HMM 204 214	recurrence
T2	HMM 971 992	endoscopic recurrence
T3	HMM 1127 1173	The primary endpoint was endoscopic recurrence
T4	HMM 1787 1816	months, endoscopic recurrence
T5	HMM 1921 1930	(p=0.03).
T6	HMM 1931 1957	Complete mucosal normality
T7	HMM 2120 2137	months recurrence
T8	HMM 2193 2205	in remission
T9	HMM 2288 2306	therapy recurrence
T10	HMM 2530 2563	the risk of endoscopic recurrence
T11	HMM 2565 2624	The incidence and type of adverse and severe adverse events
T12	HMM 2858 2888	to clinical risk of recurrence
T13	HMM 3013 3056	of postoperative Crohn's disease recurrence
T14	HMM 3150 3168	to disease control
T15	HMM 3209 3227	predict recurrence
T16	HMM 3259 3275	need monitoring.
T17	HMM 3276 3291	Early remission
